4.7 Article

SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2

Journal

NATURE IMMUNOLOGY
Volume 20, Issue 10, Pages 1311-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41590-019-0482-2

Keywords

-

Categories

Funding

  1. Gebert Ruf Foundation [GRS-058/14]
  2. Swiss National Science Foundation (SNSF) [31003A_ 172848, PP00P3_ 181038]
  3. Swiss National Supercomputing Center [SM09]
  4. Swiss National Science Foundation (SNF) [PP00P3_181038, 31003A_172848] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Whether screening the metabolic activity of immune cells facilitates discovery of molecular pathology remains unknown. Here we prospectively screened the extracellular acidification rate as a measure of glycolysis and the oxygen consumption rate as a measure of mitochondrial respiration in B cells from patients with primary antibody deficiency. The highest oxygen consumption rate values were detected in three study participants with persistent polyclonal B cell lymphocytosis (PPBL). Exome sequencing identified germline mutations in SDHA, which encodes succinate dehydrogenase subunit A, in all three patients with PPBL. SDHA gain-of-function led to an accumulation of fumarate in PPBL B cells, which engaged the KEAP1-Nrf2 system to drive the transcription of genes encoding inflammatory cytokines. In a single patient trial, blocking the activity of the cytokine interleukin-6 in vivo prevented systemic inflammation and ameliorated clinical disease. Overall, our study has identified pathological mitochondrial retrograde signaling as a disease modifier in primary antibody deficiency.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available